FIELD: cardiology. SUBSTANCE: before and after treatment, concentration of active 2-tert-butylcatechol derivatives and lag period in blood serum are determined. When lag period is increased and concentration of 2- tert-butylcatechol derivatives is lowered by at least 20%, therapy of ischemic disease is regarded effective. EFFECT: simplified procedure. 1 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PROGNOSIS OF ISCHEMIC HEART DISEASE COURSE | 1995 |
|
RU2102756C1 |
METHOD OF EVALUATION OF TOTAL ANTIOXIDANT ACTIVITY OF BLOOD | 1995 |
|
RU2116649C1 |
METHOD OF DETERMINATION OF BLOOD LIPOPROTEID FRACTIONS IN PATIENTS WITH HEART ISCHEMIC DISEASE | 2000 |
|
RU2200950C2 |
METHOD FOR EVALUATING EFFICIENCY IN TREATING ISCHEMIC CARDIAC DISEASE | 2000 |
|
RU2210075C2 |
METHOD FOR EVALUATING EFFICIENCY IN TREATING ISCHEMIC CARDIAC DISEASE | 2000 |
|
RU2210077C2 |
METHOD FOR PREDICTING THE FLOW OF ISCHEMIC CARDIAC DISEASE | 2000 |
|
RU2210076C2 |
METHOD FOR PREDICTING THE FLOW OF ISCHEMIC CARDIAC DISEASE | 2000 |
|
RU2210078C2 |
METHOD OF DETERMINATION OF BLOOD MODIFIED LIPOPROTEIN FRACTIONS | 2000 |
|
RU2210079C2 |
METHOD FOR APPLYING SECONDARY PROPHYLAXIS OF MYOCARDIAL ISCHEMIA IN EARLY PHYSICAL REHABILITATION OF MYOCARDIAL INFARCTION PATIENTS | 1998 |
|
RU2154401C2 |
METHOD FOR DIAGNOSING THE CASES OF CHRONIC CARDIAC ISCHEMIA DISEASE | 2001 |
|
RU2200951C2 |
Authors
Dates
1998-11-27—Published
1995-05-22—Filed